Category
Atomoxetine
CAS Number
2706536-33-4
Molecular Formula
C₂₇H₃₄N₂O₂
Molecular Weight
418.58 g/mol
Synonym

3,3′-[(2-methylbenzene-1,3-diyl)bis(oxy)]bis(N-methyl3-phenylpropan-1-amine); 3,3'-((2-Methyl-1,3-phenylene)bis(oxy))bis(N-methyl-3-phenylpropan-1-amine); N-Methyl-3-(2-methyl-3-(3-(methylamino)-1-phenylpropoxy)phenoxy)-3-phenylpropan-1-amine;

Keywords
Impurities
Pharmaceutical Standards
Intermediates
Fine Chemicals
Impurities Manufacturer in India
Impurities manufacturer and Suppliers in Hyderabad india
Slide_1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Atomoxetine EP Impurity G (CAS No. 2706536-33-4), molecular formula C₂₇H₃₄N₂O₂, molecular weight 418.58 g/mol, is a pharmaceutical impurity and analytical reference standard identified as 3,3′-[(2-methylbenzene-1,3-diyl)bis(oxy)]bis(N-methyl-3-phenylpropan-1-amine) and related systematic names. Manasa Life Sciences, a leading manufacturer and supplier of pharmaceutical impurities, reference standards, intermediates, and fine chemicals in India, offers Atomoxetine EP Impurity G for API impurity profiling, pharmaceutical standards, process-related impurity analysis, analytical method development, HPLC, UHPLC, LC-MS/MS, Mass Spectrometry, NMR, FTIR/IR, quality control, stability studies, method validation, and synthesis R&D. The product can be supported with COA, SDS/MSDS, specifications, and analytical documentation for pharmaceutical research and laboratory applications, aligned with applicable ICH, EMA, USP, EP, and US FDA quality and regulatory expectations.